What is identified as a potential drawback of EHR regulation?

What is identified as a potential drawback of EHR regulation?

• A. Decrease in innovative designs
• B. Increased levels of problems in contracting processes that discourage reporting flaws in EHR systems
• C. Decrease in the application of the competent human intervention principle
• D. Increase in healthcare costs to the consumer

Answer: (A)

Regulatory frameworks around EHRs can curb experimentation and risk-taking by imposing stringent standards, extensive documentation, and certification processes. This environment encourages vendors and health systems to prioritize compliance over trying novel, user-centered designs or rapid iterations. As a result, the pace of innovation in EHR design and features can slow, and new approaches that could improve usability or interoperability may be delayed or discarded because they don’t fit tightly with existing regulations. That’s why a decrease in innovative designs is identified as a potential drawback of EHR regulation. The other options describe different kinds of issues that aren’t as directly tied to regulation’s impact on design creativity. For example, concerns about contracting processes or a principle related to human intervention don’t capture the primary effect regulation often has on the evolution of EHR products. And while regulatory costs can influence the market, the most direct and commonly cited drawback related to regulation is its potential to dampen innovation.

Regulatory frameworks around EHRs can curb experimentation and risk-taking by imposing stringent standards, extensive documentation, and certification processes. This environment encourages vendors and health systems to prioritize compliance over trying novel, user-centered designs or rapid iterations. As a result, the pace of innovation in EHR design and features can slow, and new approaches that could improve usability or interoperability may be delayed or discarded because they don’t fit tightly with existing regulations. That’s why a decrease in innovative designs is identified as a potential drawback of EHR regulation.

The other options describe different kinds of issues that aren’t as directly tied to regulation’s impact on design creativity. For example, concerns about contracting processes or a principle related to human intervention don’t capture the primary effect regulation often has on the evolution of EHR products. And while regulatory costs can influence the market, the most direct and commonly cited drawback related to regulation is its potential to dampen innovation.